Switch to:

Arrowhead Pharmaceuticals Non Operating Income

: $0.0 Mil (TTM As of Jun. 2020)
View and export this data going back to 1997. Start your Free Trial

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Arrowhead Pharmaceuticals's non-recurring items for the three months ended in Jun. 2020 was $0.0 Mil. Its non-recurring items for the trailing twelve months (TTM) ended in Jun. 2020 was $0.0 Mil.

As of today (2020-10-31), Arrowhead Pharmaceuticals's share price is $57.30. Arrowhead Pharmaceuticals's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2020 was $-0.25. Therefore, Arrowhead Pharmaceuticals's PE Ratio without NRI ratio for today is .


Arrowhead Pharmaceuticals Non Operating Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arrowhead Pharmaceuticals Annual Data
Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.31 -2.29 2.20 0.44 0.00

Arrowhead Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Arrowhead Pharmaceuticals Non Operating Income Calculation

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Examples of NRI include gains (losses) from plant shutdown, lease-breaking fees, lawsuit, write-offs, write-downs, restructuring costs or sales of an investment, discontinued operations etc.

NRI can impact a company's reported income drastically.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2020 was 0 (Sep. 2019 ) + 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) = $0.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

GuruFocus lists a PE Ratio without NRI, which is the price/earnings before NRI. We believe it more accurately reflects the valuation of the company.

Arrowhead Pharmaceuticals's PE Ratio without NRI Ratio for today is calculated as

PE Ratio without NRI=Share Price/EPS without NRI
=57.30/-0.25
=

Arrowhead Pharmaceuticals's Share Price of today is $57.30.
Arrowhead Pharmaceuticals's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2020 was 0.11 (Sep. 2019 ) + -0.03 (Dec. 2019 ) + -0.2 (Mar. 2020 ) + -0.13 (Jun. 2020 ) = $-0.25.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals Non Operating Income Related Terms


Arrowhead Pharmaceuticals Non Operating Income Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)